Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Analysis of Lung Cancers Detected on CXRs and Low Dose CTs in the NLST in Women Participants Judith Amorosa Cancer Institute of New Jersey NLST Nov 29, 2011 201111-0045
Creating a resource for CAD development: Linking nodules to cancers. Paul Pinsky NCI NLST Nov 29, 2011 201111-0040
The Outcome of Micronodules (<4mm) detected on CT in NLST participants Reginald Munden M.D. Anderson Cancer Center NLST Nov 29, 2011 201111-0037
Diet and glioma: the Harvard Pooling Project Cari Kitahara NCI, DCEG, NEB PLCO Nov 28, 2011 2011-0252
Insulin and Insulin-like Growth Factor Biomarkers and Prognosis of Prostate Cancer-specific Mortality Jing Ma Brigham & Women Hospital PLCO Nov 14, 2011 2011-0181
Discrimination between Risk Profiles for Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma using Metabolomic Analysis Linda Liao NCI, DCEG, OEEB PLCO Nov 14, 2011 2011-0166
Mucins, anti-mucin antibodies and immune complexes as risk and early detection biomarkers for ovarian cancer Daniel W. Cramer Brigham and Women's Hospital PLCO Nov 14, 2011 2011-0157
Dietary fat, prediction of insulin-related and inflammatory biomarkers and pancreatic cancer risk Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Nov 3, 2011 2011-0225
Feasibility of Establishing a Second Cancer Cohort Consortium Amanda Black NCI, DCEG, EBP PLCO Nov 3, 2011 2011-0232
Risk factors for second cancers among survivors of tobacco- and alcohol-related cancers Meredith Shiels NCI, DCEG, IIB PLCO Nov 3, 2011 2011-0234
Risk factors for second cancers among colorectal cancer survivors in a cohort consortium Todd Gibson NCI, DCEG, REB PLCO Nov 3, 2011 2011-0235
Development and validation of a lung cancer risk prediction model Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0018
Development and validation of a pancreatic cancer risk prediction model Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0021
Factors associated with small aggressive NSCLC abnormal suspicious CXR screens. Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0017
Relative Survival (excess mortality) of individuals diagnosed with lung cancer in the National Lung Screening Trial. Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0019
CT Indiviual Dose Project (STARS ASA Proposal ID- 201012-0028) Michael Flynn Henry Ford Health System NLST Oct 25, 2011 201110-0020
Dietary Intake of Vitamin K and Risk of Prostate Cancer Jianjun Zhang Indiana University PLCO Oct 6, 2011 2011-0121
Obesity and incidence of rare cancers (thyroid, gallbladder, head and neck) in the NCI Cohort Consortium Cari Kitahara NCI, DCEG, NEB PLCO Oct 6, 2011 2011-0207
Male pattern baldness and prostate cancer risk: a prospective study in PLCO Michael Cook NCI, DCEG, HREB PLCO Oct 6, 2011 2011-0231
Ovarian Cancer Biomarkers: Serial CA-125 + Other Markers + Clinical Variables Stuart Baker NCI, DCP, BRG PLCO Sep 22, 2011 2011-0195